NEW YORK, NY--(Marketwired - Oct 29, 2014) -  Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of California on behalf of investors who purchased Marrone Bio Innovations, Inc. ("Marrone Bio" or the "Company") (NASDAQ: MBII) securities between March 6, 2014 and September 2, 2014.

For more information, click here: http://zlk.9nl.com/marrone-bio-innovations-mbii.

The Complaint alleges that the Company made materially false and/or misleading statements and/or failed to disclose that: (a) Marrone's financial statements contained errors related to the improper recognition of revenues; (b) the Company lacked adequate internal controls over financial reporting; and (c) as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

On September 3, 2014, the Company announced that some of its previously-issued financial statements should no longer be relied upon, and that the Audit Committee of the Company's Board had commenced an internal investigation.

If you suffered a loss in Marrone Bio you have until November 4, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/marrone-bio-innovations-mbii. 

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.